Table 2 Percentages of seropositivity for anti-carbamylated antibodies and various citrullinated peptides and their native arginine counterparts according to cutoff levels of >2 SD above the mean of healthy controls
Patient group | Healthy controls | Periodontitis | Bronchiectasis | Cystic fibrosis | Rheumatoid arthritis |
|---|---|---|---|---|---|
Anti-CarP IgG (% pos.) | 0 | 3.5 | 3.8 | 7.3 | 48 |
Peptides IgG (% pos.) | |||||
Cit. fibrinogen-1 | 2.8 | 0.9 | 1.3 | 0 | 55 |
Arg. fibrinogen-1 | 0 | 0.9 | 1.3 | 2.4 | 0 |
Cit. fibrinogen-2 | 0 | 4.4 | 2.5 | 0 | 71 |
Arg. fibrinogen-2 | 2.8 | 3.5 | 3.8 | 4.9 | 2.3 |
Cit. α-enolase | 0 | 0.9 | 2.5 | 0 | 38 |
Arg. α-enolase | 2.8 | 1.8 | 6.3 | 4.9 | 1.2 |
Cit. vimentin | 0 | 1.8 | 0 | 0 | 48 |
Arg. vimentin | 5.6 | 5.3 | 1.3 | 7.3 | 1.2 |
Peptide IgA (% pos.) | |||||
Cit. fibrinogen-1 | 0 | 0.9 | 0 | 0 | 8.1 |
Arg. fibrinogen-1 | 2.8 | 0.9 | 2.5 | 0 | 0 |
Cit. fibrinogen-2 | 2.8 | 2.6 | 0 | 0 | 19 |
Arg. fibrinogen-2 | 0 | 7.9 | 2.5 | 9.8 | 4.7 |
Cit. α-enolase | 0 | 2.6 | 0 | 0 | 7.0 |
Arg. α-enolase | 8.3 | 2.6 | 6.3 | 7.3 | 4.7 |
Cit. vimentin | 0 | 0 | 0 | 0 | 4.7 |
Arg. vimentin | 5.6 | 4.4 | 2.5 | 4.9 | 2.3 |